149 related articles for article (PubMed ID: 31782613)
1. Accuracy of HAS-BLED and other bleeding risk assessment tools in predicting major bleeding events in atrial fibrillation: A network meta-analysis.
Chang G; Xie Q; Ma L; Hu K; Zhang Z; Mu G; Cui Y
J Thromb Haemost; 2020 Apr; 18(4):791-801. PubMed ID: 31782613
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Accuracy of the HAS-BLED Bleeding Score in VKA- or DOAC-Treated Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Gao X; Cai X; Yang Y; Zhou Y; Zhu W
Front Cardiovasc Med; 2021; 8():757087. PubMed ID: 34881309
[No Abstract] [Full Text] [Related]
3. Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores.
Proietti M; Rivera-Caravaca JM; Esteve-Pastor MA; Romiti GF; Marin F; Lip GYH
J Am Heart Assoc; 2018 Sep; 7(18):e009766. PubMed ID: 30371183
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis on performance of ABC and GARFIELD-AF compared to CHA
Ali A; Siddiqui AA; Ali M; Shahid I
Cardiovasc Revasc Med; 2024 Mar; 60():74-81. PubMed ID: 37880043
[TBL] [Abstract][Full Text] [Related]
5. Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project.
Guo YT; Zhang Y; Shi XM; Shan ZL; Wang CJ; Wang YT; Chen YD; Lip GY
Sci Rep; 2016 Aug; 6():31755. PubMed ID: 27557876
[TBL] [Abstract][Full Text] [Related]
6. Comparative validation of HAS-BLED, GARFIELD-AF and ORBIT bleeding risk scores in Asian people with atrial fibrillation treated with oral anticoagulant: A report from the COOL-AF registry.
Chichareon P; Winijkul A; Lip GYH; Krittayaphong R
Br J Clin Pharmacol; 2023 Aug; 89(8):2472-2482. PubMed ID: 36942465
[TBL] [Abstract][Full Text] [Related]
7. Comparison of HAS-BLED with other risk models for predicting the bleeding risk in anticoagulated patients with atrial fibrillation: A PRISMA-compliant article.
Zeng J; Yu P; Cui W; Wang X; Ma J; Zeng C
Medicine (Baltimore); 2020 Jun; 99(25):e20782. PubMed ID: 32569222
[TBL] [Abstract][Full Text] [Related]
8. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
[TBL] [Abstract][Full Text] [Related]
9. Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis.
Caldeira D; Costa J; Fernandes RM; Pinto FJ; Ferreira JJ
J Interv Card Electrophysiol; 2014 Sep; 40(3):277-84. PubMed ID: 25012972
[TBL] [Abstract][Full Text] [Related]
10. GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.
Fox KAA; Virdone S; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Oto A; Misselwitz F; Piccini JP; Dalgaard F; Turpie AGG; Verheugt FWA; Kakkar AK;
Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):214-227. PubMed ID: 33892489
[TBL] [Abstract][Full Text] [Related]
11. Comparing Bleeding Risk Assessment Focused on Modifiable Risk Factors Only Versus Validated Bleeding Risk Scores in Atrial Fibrillation.
Guo Y; Zhu H; Chen Y; Lip GYH
Am J Med; 2018 Feb; 131(2):185-192. PubMed ID: 28943382
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.
Roldán V; Marín F; Fernández H; Manzano-Fernandez S; Gallego P; Valdés M; Vicente V; Lip GYH
Chest; 2013 Jan; 143(1):179-184. PubMed ID: 22722228
[TBL] [Abstract][Full Text] [Related]
13. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation.
O'Brien EC; Simon DN; Thomas LE; Hylek EM; Gersh BJ; Ansell JE; Kowey PR; Mahaffey KW; Chang P; Fonarow GC; Pencina MJ; Piccini JP; Peterson ED
Eur Heart J; 2015 Dec; 36(46):3258-64. PubMed ID: 26424865
[TBL] [Abstract][Full Text] [Related]
14. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
[TBL] [Abstract][Full Text] [Related]
15. Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.
Esteve-Pastor MA; Rivera-Caravaca JM; Roldan V; Vicente V; Valdés M; Marín F; Lip GYH
Thromb Haemost; 2017 Oct; 117(10):1848-1858. PubMed ID: 28799620
[TBL] [Abstract][Full Text] [Related]
16. Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study.
Chao TF; Lip GYH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
Int J Cardiol; 2018 Mar; 254():157-161. PubMed ID: 29407081
[TBL] [Abstract][Full Text] [Related]
17. Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Kiviniemi T; Puurunen M; Schlitt A; Rubboli A; Karjalainen P; Vikman S; Niemelä M; Lahtela H; Lip GY; Airaksinen KE
Am J Cardiol; 2014 Jun; 113(12):1995-2001. PubMed ID: 24793675
[TBL] [Abstract][Full Text] [Related]
18. The HAS-BLED, ATRIA, and ORBIT Bleeding Scores in Atrial Fibrillation Patients Using Non-Vitamin K Antagonist Oral Anticoagulants.
Lip GYH; Skjøth F; Nielsen PB; Kjældgaard JN; Larsen TB
Am J Med; 2018 May; 131(5):574.e13-574.e27. PubMed ID: 29274754
[TBL] [Abstract][Full Text] [Related]
19. Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores.
Proietti M; Senoo K; Lane DA; Lip GY
Sci Rep; 2016 Apr; 6():24376. PubMed ID: 27067661
[TBL] [Abstract][Full Text] [Related]
20. Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
Senoo K; Lip GY
Int J Cardiol; 2016 Oct; 221():379-82. PubMed ID: 27409565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]